Opus Genetics, Inc.
IRD- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001228627
In the last 90 days, Opus Genetics, Inc. insiders filed 0 open-market purchases and 5 sales; 103 institutions reported holding it in 13F filings for Q2 2026, worth $236.4M in total; no superinvestor holds it.
Q4 2024 vs. Q3 2024
How the institutions holding Opus Genetics, Inc. changed between Q3 2024 and Q4 2024.
All holders in Q4 2024All holders in Q3 2024
| Measure | Q3 2024 | Of which not filed for Q4 2024 | Q4 2024 | Change |
|---|---|---|---|---|
| Holders | 38 | 1 | 43 | +6 |
| Shares | 2.53M | 11.8K | 3.68M | +1.16M (+46.0%) |
| Value | $3.32M | $15.4K | $4.38M | +$1.08M (+32.6%) |
1 institution that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (14)
Institutions that held Opus Genetics, Inc. at the end of Q4 2024 but not at the end of Q3 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| BIOS Capital Management, LP | 995,249 | $1.18M | 1.26% |
| Voss Capital, LLC | 190,958 | $227.2K | 0.02% |
| Apollon Wealth Management, LLC | 28,089 | $33.4K | 0.00% |
| SBI Securities Co., Ltd. | 24,960 | $29.7K | 0.00% |
| Jane Street Group, LLC | 18,353 | $21.8K | 0.00% |
| Financial Gravity Companies, Inc. | 16,555 | $19.7K | 0.00% |
| Two Sigma Securities, LLC | 16,202 | $19.3K | 0.00% |
| Raymond James Financial Inc | 14,980 | $17.8K | 0.00% |
| Millennium Management LLC | 11,991 | $14.3K | 0.00% |
| Reliant Investment Partners, LLC | 10,000 | $11.9K | 0.01% |
| MAI Capital Management | 999 | $1.19K | 0.00% |
| Richards, Merrill & Peterson, Inc. | 70 | $83 | 0.00% |
| Northwestern Mutual Wealth Management Co | 10 | $12 | 0.00% |
| FMR LLC | 1 | $1 | 0.00% |
Sold out (8)
Institutions that held Opus Genetics, Inc. at the end of Q3 2024 and filed for Q4 2024 without it.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| Richmond Brothers, Inc. | 155,620 | $203.9K |
| Susquehanna International Group, LLP | 49,755 | $65.2K |
| Virtu Financial LLC | 23,728 | $31.0K |
| Prelude Capital Management, LLC | 12,110 | $15.9K |
| Commonwealth Equity Services, LLC | 11,739 | $15.0K |
| Barclays PLC | 1,900 | $2.49K |
| Harbour Investments, Inc. | 40 | $52 |
| FSA Wealth Management LLC | 5 | $7 |
Not filed for Q4 2024 yet (1)
Institutions that held Opus Genetics, Inc. at the end of Q3 2024 and haven't filed a 13F for Q4 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| Raymond James & Associates | 11,758 | $15.4K |